APGE
APOGEE THERAPEUTICS Buyout Closes as Shares Head for Delisting
An 8-K filing shows Apogee Therapeutics has completed a change-of-control transaction, replaced its board and recapitalized to just 1,000 shares.
APGE
Market-moving news on Apogee Therapeutics (NASDAQ: APGE): filings, earnings, deals and other events, from REDFILED.